Drug intelligence / Profile preview

PANFIRST

Development stage
Unknown
Lead developer
Sinsan Pharmaceuticals
Modality
Small Molecules
01

Overview

**PANFIRST** is a Sinsan Pharmaceuticals gastrointestinal prescription-product brand family rather than one chemically specific drug. Public product listings identify **PANFIRST 40** as pantoprazole 40 mg, a proton-pump inhibitor that suppresses gastric acid secretion through irreversible inhibition of the gastric H+/K+-ATPase. They identify **PANFIRST D** as a pantoprazole plus domperidone product, combining acid suppression with dopamine D2 receptor antagonism to promote upper-gastrointestinal motility and reduce nausea. The PANFIRST brand family is used for acid-related gastrointestinal conditions, including gastroesophageal reflux disease, dyspepsia, and peptic ulcer disease; however, the exact active ingredients, dosage form, route, and mechanism depend on the named PANFIRST variant.

Brand names
PANFIRST
02

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on PANFIRST.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PANFIRST.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call